Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

50.15
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
46.43
Today|||52-Week Range
63.40
-9.78%
Year-to-Date

Today’s Trading

Previous close50.15
Today’s open49.56
Day’s range49.38 - 50.30
Volume454,204
Average volume (3 months)800,945
Market cap$7.6B
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+88.83%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book6.22

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...0.000.00%
SGENSeattle Genetics Inc0.000.00%
TSROTESARO Inc0.000.00%
IONSIonis Pharmaceutical...0.000.00%
Data as of 4:00pm ET, 11/22/2017

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$0.14
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts